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In this issue Khalil et al. report the findings of a systematic review of studies reporting 
placental histological features in relation to pre-eclampsia (PET).1 The main findings of this 
study were first, that whilst certain histological patterns were more common in PET than 
controls, similar features were also noted in unaffected cases, and secondly, that the results 
were related to whether the histological features in the studies were assessed blindly, with 
significantly greater apparent differences between groups reported in unblinded studies. 
These results demonstrate the impact of bias, which may be unconscious, on study 
outcome, with important implications for appropriate interpretation of not only placental 
pathology studies, but all such studies with a potentially subjective element of 
interpretation. 
 
The scientific investigation of errors in how we think and make decisions is now well 
established,2 this area resulting in the Nobel prize in economics in 2002,3 although there is 
relatively little published specifically in relation to medicine in relation to thinking and 
interpretation. Potential pitfalls described in general include subconscious bias without 
blinding, selection bias, confirmation bias, hindsight bias and many more.4  
 
Specifically, there are several areas of potential methodological difficulty with retrospective 
studies of placental findings. First, many such studies are based on review of a subgroup of 
cases which were submitted as part of clinical care, usually to a specialist centre, which 
results in marked preselection of pregnancies, increasing the proportion of affected cases in 
the overall group. Whilst this in itself may not necessarily affect the odds ratio for detecting 
associations between histological features and outcome, it has a significant effect on the 
positive predictive value of the test when used in clinical practice and hence the overall 
strength of association. True characteristics of such associations can only be determined 
from studies in which large, unselected populations are included rather than highly 
preselected groups based on pregnancy complications, which by definition enhance for the 
outcome in question.5 
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This factor is of much greater importance for evaluating histological findings in the placenta 
compared to those in tumour specimens, for example, since many tumours have highly 
characteristic features which are never seen in ‘normal’ patients and hence such ‘abnormal’ 
cases are easily recognised regardless of their prevalence in a population. In contrast, many 
of the features noted in the placentas from pregnancies complications with PET and fetal 
growth restriction are also reported in apparently uncomplicated pregnancies; it is the 
frequency and severity of such findings which are increased in PET.1 For this reason, it is 
apparent that if one were to take a hypothetical group of 100 placentas, in whom 90 were 
affected by PET (assume 50% showed histological abnormalities) with 10 unaffected 
controls (assuming 10-20% showed histological abnormalities), the ‘test characteristics’ for 
the histological feature in question to detect PET would appear good. However, if the same 
90 PET cases were now included as part of a larger group of 1,000 placentas, in which the 
other 910 were unaffected, the success with which pathological evaluation could correctly 
identify PET cases would significantly reduce.  
Furthermore, by definition, cases submitted for routine placental histopathological 
evaluation as part of clinical care are reported in full knowledge of the clinical history. This 
leads to significant potential for subconscious subjective bias in the recognition and 
reporting of features, both positive and negative depending on the clinical history. The 
effect of non-blinding is clearly illustrated by the findings of the present study, in which 
studies without pathologist blinding reported greater differences between the PET and 
normal outcome groups, with consequent erroneous overestimation the significance of the 
feature examined.1 The effect of clinical history on subjective evaluation of placentas can be 
further illustrated by a study in which a group of placental pathologists were provided with 
histological sections each accompanied by a clinical history, and asked to estimate the 
gestational age. Subsequent sets were circulated for similar evaluation, but unknown to 
those participating, these were the same as the first set but with changed clinical histories, 
and the clinical history provided influenced the ‘histologically evaluated’ gestational age.6  
These factors highlight the potential methodological difficulties from unblinded 
retrospective histological reviews, or worse still, reviews of clinical histology reports from a 
diagnostic laboratory service, for research purposes. Prospective, blinded studies from 
unselected populations with evaluation independent of any clinical features have 
demonstrated that many histological features are present in both normal and complicated 
pregnancies, but with differing frequencies. Similar odds ratios to retrospective studies for 
associations with outcome and specific histological ‘abnormalities’ are reported but such 
unselected, blinded studies also provide data to determine other test characteristics. For 
example, in one study of >1,000 unselected low risk pregnancies the odds ratio for the 
association of villitis of unknown aetiology (VUE) and pregnancy induced hypertension was 
around 3, similar to case-control studies, but since VUE was also reported in clinically 
uncomplicated pregnancies, (which are not normally examined by diagnostic pathology 
departments), for any given unselected case in which VUE was present, there was a >90% 
chance that this apparent abnormality was an incidental and clinically insignificant finding in 
an uncomplicated pregnancy rather than a marker of patients with PIH.5     
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The recognition and publication of such factors is therefore important to ensure appropriate 
and accurate interpretation of histological features for future studies. As illustrated by the 
present study, histopathological examination of the placenta can provide important 
information regarding underlying pathophysiological mechanisms, and in future, may guide 
personalised care in subsequent pregnancies. Specifically, in PET it is recognised that early 
onset disease is associated with more typical maternalvascular malperfusion type changes 
whereas late onset disease may show minimal histological abnormalities, supporting the 
hypothesis of differing maternal and fetal mechanisms for subtypes of PET.7,8 Nevertheless, 
interpretation of histological findings in individual cases remains uncertain and awareness of 
the potential methodological pitfalls, as highlighted by the current review, should lead to 
improved quality of future studies on which to base strategic decisions regarding research 
and patient management. 
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